Increased numbers of CD5+CD19+CD1dhighIL-10+ Bregs, CD4+Foxp3+ Tregs, CD4+CXCR5+Foxp3+ follicular regulatory T (TFR) cells in CHB or CHC patients

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Wang, Li ^a   Qiu, Jinpeng ^a   Yu, Lei ^b   Hu, Xiaoli ^c   Zhao, Pingwei ^a   Jiang, Yanfang ^a,d  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Heilongjiang Power Hospital   (China)

^d JIAMUSI UNIVERSITY   (China)

Author keywords

Breg; Chronic hepatitis B (CHB); Chronic hepatitis C (CHC); Follicular regulatory T (TFR); Forkhead box protein 3 (Foxp3); HBsAg; IL 10; T follicular helper (TFH)

Indexed keywords

ALANINE AMINOTRANSFERASE; CD19 ANTIGEN; CD1D ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; HEPATITIS B(E) ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3; VIRUS DNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; B LYMPHOCYTE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLICULAR REGULATORY T LYMPHOCYTE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS LOAD;

EID: 84908130969     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-014-0251-9     Document Type: Article

References (50)

1. Li XD, Wang L, Liu Y, Xu ZH, Dai JZ, Li L, Yao ZT, Zhao JM, Xu DP. Characterization of hepatitis B virus genotypes /subgenotypes in 1301 patients with chronic hepatitis B in North China. Chin Med J (Engl) 2011, 124:4178-4183.
2. Chen GC, Yu T, Huang KH, Chen QK. Antiviral therapy of decompensated hepatitis B virus-related cirrhosis. Chin Med J (Engl) 2012, 125:373-377.
3. Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, Shiffman ML, Lawitz E, Everson G, Bennett M, Schiff E, Al-Assi MT, Subramanian GM, An D, Lin M, McNally J, Brainard D, Symonds WT, McHutchison JG, Patel K, Feld J, Pianko S, Nelson DR, George J, Leggett B, Pianko S, Thompson A, Elkashab M, et al. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options. N Engl J Med 2013, 368:1867-1877. 10.1056/NEJMoa1214854, 23607593.
4. Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection. Gut 2012, 61:1754-1764. 10.1136/gutjnl-2011-301073, 22157327.
5. Walker CM. Adaptive immunity to the hepatitis C virus. Adv Virus Res 2010, 78:43-86. 10.1016/B978-0-12-385032-4.00002-1, 21040831.
6. Ji XJ, Ma CJ, Wang JM, Wu XY, Niki T, Hirashima M, Moorman JP, Yao ZQ. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway. Eur J Immunol 2013, 43:458-467. 10.1002/eji.201242768, 23161469.
7. Jiang YF, Jin QL, Li WY. An analysis of CD4 + CD25 + CD127low/- regulatory T cells and their immunological functions in patients with primary biliary cirrhosis. Zhonghua Gan Zang Bing Za Zhi 2008, 16:620-621. 18752752.
8. Ma L, Zhao P, Jiang Z, Shan Y, Jiang Y. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol 2013, 174:345-355. 10.1111/cei.12189, 23968502.
9. Shevach EM. Biological functions of regulatory T cells. Adv Immunol 2011, 112:137-176. 10.1016/B978-0-12-387827-4.00004-8, 22118408.
10. Li J, Shi J, Ren W, Wu W, Chen Z. Regulatory role of CD4(+)CD25 (+)Foxp3 (+) regulatory T cells on IL-17-secreting T cells in chronic hepatitis B patients. Dig Dis Sci 2014, 59:1475-1483. 10.1007/s10620-013-3022-1, 24442238.
11. Claassen MA, de Knegt RJ, Tilanus HW, Janssen HL, Boonstra A. Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis. J Hepatol 2010, 52:315-321. 10.1016/j.jhep.2009.12.013, 20129690.
12. Berthelot JM, Jamin C, Amrouche K, Le Goff B, Maugars Y, Youinou P. Regulatory B cells play a key role in immune system balance. Joint Bone Spine 2013, 80:18-22. 10.1016/j.jbspin.2012.04.010, 22858147.
13. DiLillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011, 49:281-292. 10.1007/s12026-010-8189-3, 21125343.
14. Hussaarts L, van der Vlugt LE, Yazdanbakhsh M, Smits HH. Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol 2011, 128:733-739. 10.1016/j.jaci.2011.05.012, 21684587.
15. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012, 30:221-241. 10.1146/annurev-immunol-020711-074934, 22224776.
16. Ronet C, Hauyon-La Torre Y, Revaz-Breton M, Mastelic B, Tacchini-Cottier F, Louis J, Launois P. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol 2010, 184:886-894. 10.4049/jimmunol.0901114, 19966209.
17. DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann N Y Acad Sci 2010, 1183:38-57. 10.1111/j.1749-6632.2009.05137.x, 20146707.
18. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, Szabolcs PM, Bernstein SH, Magro CM, Williams AD, Hall RP, St Clair EW, Tedder TF. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011, 117:530-541. 10.1182/blood-2010-07-294249, 20962324.
19. Poe JC, Smith SH, Haas KM, Yanaba K, Tsubata T, Matsushita T, Tedder TF. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 2011, 6:e22464. 10.1371/journal.pone.0022464, 21799861.
20. Ray A, Basu S, Williams CB, Salzman NH, Dittel BN. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J Immunol 2012, 188:3188-3198. 10.4049/jimmunol.1103354, 22368274.
21. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650. 10.1016/j.immuni.2008.03.017, 18482568.
22. Yanaba K, Yoshizaki A, Asano Y, Kadono T, Tedder TF, Sato S. IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model. Am J Pathol 2011, 178:735-743. 10.1016/j.ajpath.2010.10.022, 21281806.
23. Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D, Chen A, Blair P, Dusheiko G, Gill U, Kennedy PT, Brunetto M, Lampertico P, Mauri C, Maini MK. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012, 189:3925-3935. 10.4049/jimmunol.1103139, 22972930.
24. Linterman MA, Liston A, Vinuesa CG. T-follicular helper cell differentiation and the co-option of this pathway by non-helper cells. Immunol Rev 2012, 247:143-159. 10.1111/j.1600-065X.2012.01121.x, 22500838.
25. Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S, Wang YH, Lim H, Reynolds JM, Zhou XH, Fan HM, Liu ZM, Neelapu SS, Dong C. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011, 17:983-988. 10.1038/nm.2426, 21785430.
26. Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF, Srivastava M, Divekar DP, Beaton L, Hogan JJ, Fagarasan S, Liston A, Smith KG, Vinuesa CG. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 2011, 17:975-982. 10.1038/nm.2425, 21785433.
27. Wollenberg I, Agua-Doce A, Hernandez A, Almeida C, Oliveira VG, Faro J, Graca L. Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells. J Immunol 2011, 187:4553-4560. 10.4049/jimmunol.1101328, 21984700.
28. Cardoso AC, Carvalho-Filho RJ, Stern C, Dipumpo A, Giuily N, Ripault MP, Asselah T, Boyer N, Lada O, Castelnau C, Martinot-Peignoux M, Valla DC, Bedossa P, Marcellin P. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2012, 32:612-621. 10.1111/j.1478-3231.2011.02660.x, 22103765.
29. Morgan E, Varro R, Sepulveda H, Ember JA, Apgar J, Wilson J, Lowe L, Chen R, Shivraj L, Agadir A, Campos R, Ernst D, Gaur A. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 2004, 110:252-266. 10.1016/j.clim.2003.11.017, 15047203.
30. Feng J, Hu X, Guo H, Sun X, Wang J, Xu L, Jiang Z, Xu B, Niu J, Jiang Y. Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells. J Gastroenterol 2012, 47:1048-1056. 10.1007/s00535-012-0568-1, 22426636.
31. Feng J, Lu L, Hua C, Qin L, Zhao P, Wang J, Wang Y, Li W, Shi X, Jiang Y. High frequency of CD4+ CXCR5+ TFH cells in patients with immune-active chronic hepatitis B. PLoS One 2011, 6:e21698. 10.1371/journal.pone.0021698, 21750724.
32. Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A, Klenerman P. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005, 41:1019-1028. 10.1002/hep.20669, 15841456.
33. Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol 2010, 40:2686-2691. 10.1002/eji.201040673, 20809522.
34. Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis 2002, 2:43-50. 10.1016/S1473-3099(01)00172-4, 11892495.
35. Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013, 19:850-858. 10.1038/nm.3184, 23836235.
36. Dalia S, Chavez J, Castillo JJ, Sokol L. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Leuk Res 2013, 37:1107-1115. 10.1016/j.leukres.2013.06.007, 23809055.
37. Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 2013, 57:37-45. 10.1002/hep.25988, 22858989.
38. Mauri C. Regulation of immunity and autoimmunity by B cells. Curr Opin Immunol 2010, 22:761-767. 10.1016/j.coi.2010.10.009, 21087847.
39. Yamaguchi T, Wing JB, Sakaguchi S. Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions. Semin Immunol 2011, 23:424-430. 10.1016/j.smim.2011.10.002, 22055883.
40. Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004, 40:1062-1071. 10.1002/hep.20454, 15486925.
41. Ward SM, Fox BC, Brown PJ, Worthington J, Fox SB, Chapman RW, Fleming KA, Banham AH, Klenerman P. Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection. J Hepatol 2007, 47:316-324. 10.1016/j.jhep.2007.03.023, 17475362.
42. Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI, Spolski R, Poe JC, Leonard WJ, Tedder TF. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012, 491:264-268. 10.1038/nature11501, 23064231.
43. Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009, 182:7459-7472. 10.4049/jimmunol.0900270, 19494269.
44. Barnaba V, Levrero M, Van Dyke AD, Musca A, Cordova C, Balsano F. T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection. Clin Immunol Immunopathol 1985, 34:284-295. 10.1016/0090-1229(85)90177-1, 2578908.
45. Rehermann B, Chang KM, McHutchinson J, Kokka R, Houghton M, Rice CM, Chisari FV. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996, 70:7092-7102. 8794355.
46. Sage PT, Francisco LM, Carman CV, Sharpe AH. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood. Nat Immunol 2013, 14:152-161. 10.1038/ni.2496, 23242415.
47. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, Abrignani S, Mondelli MU, Barnaba V. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004, 113:963-972. 10.1172/JCI200420515, 15057302.
48. Franzese O, Kennedy PT, Gehring AJ, Gotto J, Williams R, Maini MK, Bertoletti A. Modulation of the CD8 + -T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol 2005, 79:3322-3328. 10.1128/JVI.79.6.3322-3328.2005, 15731226.
49. Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2012, 27(Suppl 2):89-93. 10.1111/j.1440-1746.2011.07003.x, 22320924.
50. Hong F, Kim WH, Tian Z, Jaruga B, Ishac E, Shen X, Gao B. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 2002, 21:32-43. 10.1038/sj.onc.1205016, 11791174.